All Stories

  1. HIV / AIDS in transition: Global disparities, Africa's uneven progress and struggles, and the emerging threat of funding cuts (global burden of disease study, 1990–2021)
  2. Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study...
  3. Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
  4. Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950–2023: a demographic analysis for the Global Burden of Disease Study 2023
  5. The global, regional, and national burden of cancer, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023
  6. GBD 2023 Cardiovascular Disease Collaborators
  7. Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023
  8. Rising global threat of human metapneumovirus (hMPV in 2024/2025): pathogenesis, immune dynamics, vulnerabilities in immunocompromised individuals, and lessons from past pandemics
  9. Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
  10. Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
  11. Anti-proliferative effects of a polyherbal formulation on HL-60, HCT-116, and HeLa cell lines: a docking simulation and response surface design-aided study
  12. 2024 Acknowledgment of Microbiology Spectrum Ad Hoc Reviewers
  13. From complexity to clarity: unravelling tumor heterogeneity through the lens of tumor microenvironment for innovative cancer therapy
  14. Melatonin and its derivatives
  15. Expression Patterns of ER, PR, HER-2/neu and p53 in Association with Nottingham Tumour Grade in Breast Cancer Patients
  16. Multi-Fold Computational Analysis to Explore JAK2 and STAT5 Potential Inhibitors for Modulation of Cancer
  17. EMT-induced immune evasion: connecting the dots from mechanisms to therapy
  18. Nanodelivery of Polyphenols as Nutraceuticals in Anticancer Interventions
  19. Antipyretic Agents from Plant Origins
  20. Phytochemicals and bioactive compounds effective against acute myeloid leukemia: A systematic review
  21. Wnt/β‐catenin signaling pathway inhibitors, glycyrrhizic acid, solanine, polyphyllin I, crocin, hypericin, tubeimoside‐1, diosmin, and rutin in medicinal plants have better binding affinities and anticancer properties: Molecular docking and ADMET<...
  22. The Roles of Oxylipin Biosynthesis Genes in Programmed Cell Death
  23. Therapeutic potentials of medicinal plants and significance of computational tools in anti-cancer drug discovery
  24. Synchronicity of P53 Mutation and Multiple High-Risk HPV Genotypes, and the Risk of Cervical Cancer among Women in Osogbo, Nigeria
  25. Understanding the Complex Milieu of Epithelial-Mesenchymal Transition in Cancer Metastasis: New Insight Into the Roles of Transcription Factors
  26. Early stage nonclinical pulmonary disorder in COVID-19 may present asymptomatic and fuel the contagion
  27. Addressing the global surge of COVID-19 cases: insights from diagnostics, improved treatment strategies, vaccine development and application
  28. Ebola outbreak in West Africa, 2014 – 2016: Epidemic timeline, differential diagnoses, determining factors, and lessons for future response
  29. A close look at the biology of SARS-CoV-2, and the potential influence of weather conditions and seasons on COVID-19 case spread
  30. Public health preparedness towards COVID-19 outbreak in Nigeria
  31. Prostate Tuberculosis
  32. Glycemic control and its impact on oxidative stress biomarkers in type 2 diabetic patients treated with metformin: a cross-sectional analysis
  33. Assessment of iron status and interplay between lipid peroxidation and antioxidant capacity in common hemoglobin variants in Osun State, southwestern Nigeria
  34. Antioxidant and chemotherapeutic effects of trèvo®supplement on benzene-induced leukaemia in murine models
  35. In-vitro anti-sickling and membrane stability potentials of Mishenland polyherbal extract on sickle red blood cells
  36. Hepatoprotective Potential of Russelia Equisetiformis Plant Extract on Drug-Induced Hepatotoxicity in Experimental Models
  37. CD4+ Cell Count, Lipid And Lipoprotein Levels In Hiv Patients On Drug Treatment